High expression of NEK2 promotes gastric cancer progression via activating AKT signaling.

Journal of Physiology and Biochemistry
Hao WanTaiyuan Li

Abstract

Never in mitosis gene A-related kinase 2 (NEK2) has been recognized as an oncogene involved in the initiation and progression of various human cancers. However, our knowledge is still lacking in regard to the function of NEK2 in gastric cancer, the most common cancer in Eastern Asia associated with poor prognosis. Therefore, in the present study, we investigated the association of NEK2 with gastric cancer. We found that the development of gastric cancer is associated with NEK2 overexpression, particularly in patients with large tumor size and lymph node metastasis. We also provided evidence that NEK2 overexpression binds to and inhibits protein phosphatase 1 (PP1), which subsequently activates AKT and the downstream oncogenic pathways. As a result, via AKT/HIF1α axis, the glucose metabolism is reprogrammed towards aerobic glycolysis to provide rapid energy for the growth of gastric cancer cells. Moreover, the autophagic activity is suppressed via AKT/mTOR axis, leading to impaired response to cancer treatment and enhanced cell survival. In contrast, inactivating AKT by NEK2 silencing decreases aerobic glycolysis and promotes autophagic cell death, which eventually inhibits the growth of gastric cancer cell. All these results re...Continue Reading

References

Feb 21, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Sven de VosJonathan W Said
Feb 24, 1956·Science·O WARBURG
Nov 22, 2011·Cell Cycle·Angelika S Rambold, Jennifer Lippincott-Schwartz
Jun 19, 2013·PloS One·Mary Kathryn Harrison Pitner, Harold I Saavedra
Oct 12, 2013·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Eva M Palsson-McDermott, Luke A J O'Neill
Dec 18, 2013·Oncology Reports·Xia LiuFuqiang Yin
Dec 27, 2013·Nucleic Acids Research·Chiara NaroClaudio Sette
Jan 7, 2014·Frontiers in Bioscience (Landmark Edition)·Mihaela Marina, Harold I Saavedra
May 2, 2014·World Journal of Gastroenterology : WJG·Rubayat RahmanJamal A Ibdah
Sep 18, 2014·Oncotarget·Ye YangFenghuang Zhan
Oct 17, 2014·World Journal of Gastroenterology : WJG·Jing ShiPeng Hou
Mar 29, 2016·Cell Cycle·Yanfen Fang, Xiongwen Zhang
Aug 4, 2016·Proceedings of the National Academy of Sciences of the United States of America·Igor CervenkaVitezslav Bryja
Feb 12, 2017·Cell·Matthew G Vander Heiden, Ralph J DeBerardinis
Feb 16, 2018·Cancer Management and Research·Robert SitarzWojciech P Polkowski
Jun 5, 2018·The Journal of Clinical Investigation·Reinaldo Franqui-MachinFenghuang Zhan
Dec 19, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·YuSheng ChengYang Yang
Jun 9, 2019·Journal of Experimental & Clinical Cancer Research : CR·Honghong ShenChen Wang
Jun 30, 2019·World Journal of Gastroenterology : WJG·Wei-Dong FanPeng-Jun Liu
Sep 27, 2019·Cancers·Akpedje S Dossou, Alakananda Basu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy Networks

Autophagy is a lysosomal pathway that involves degradation of proteins and functions in normal growth and pathological conditions, through a series of complex networks. The catabolic process involves delivery of proteins and organelles to the lysosome. Here is the latest research on autophagy networks.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.